weight loss medication retatrutide Who Makes Retatrutide? Company Behind the Drug Retatrutide, a new weight loss

Summary: Retatrutide FDA Status Retatrutide is not FDA-approved and won't be for at least another year It's in Phase 3 trials (TRIUMPH program) with results expected in late 2026 FDA approval is projected for 20272028 Phase 2 data showed 24.2% weight loss , better than any approved GLP-1 medication Current access: clinical trials (free), compounded retatrutide ($200$500/mo), or research peptides ($150$500/mo) When approved, retatrutide will be the first triple-agonist obesity medication on the market References Jastreboff AM, Aronne LJ, Ahmad NN, et al

Finally, when considering gut irritation and alcohol consumption, there is the issue of bloating, gas, and general digestive discomfort

Safety and tolerability also remain key considerations

Alan recommends contacting your health insurance provider directly to ask

Why dont you give our office a call to schedule a phone consult